ABSTRACT

Fact Sheet for Healthcare Providers: Luminex Corporation, xMAP® SARS-CoV-2 Multi-Antigen IgG Assay   [open pdf - 113KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the xMAP® SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Multi-Antigen IgG [Immunoglobulin G] Assay. The xMAP® SARS-CoV-2 Multi-Antigen IgG Assay is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum and plasma."

Publisher:
Date:
2020-07-16
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations